Sponsors & Exhibitors

Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company. Cepheid’s GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way to perform world-class PCR...

Flourish Research is a diversified clinical trial company designed to acquire, operate, and integrate best-in-class clinical research sites with expertise in studies spanning Phases I-IV. Flourish was founded to address the highly fragmented...

Sanyou Biopharmaceuticals Co., Ltd. is a world-leading high-tech biotechnology enterprise focusing on R&D and services of innovative biological drugs. Sanyou is committed to establishing an internationally leading high-quality, high-throughput...

With over 35 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics...

VaxTrials is a regional boutique clinical research organization (CRO) that provides end-to-end monitoring, site management and project management solutions for vaccine projects in Latin America. 

Velocity Clinical Research is the world’s leading site organization, comprising 80 owned and integrated clinical research sites empowered by 225 investigators across the U.S. and Europe. Velocity partners with pharmaceutical and biotechnology...

Ainnocence is a next-generation biotech company with a fast, self-evolving AI drug design platform. The company's third-generation AI system delivers lightning-fast virtual screening and multi-objective pharmacological profile optimization for...

Apex Research Group (ARG) is a clinician-led clinical research site organization. We are committed to preserving the health and  well-being of the general population by being a liaison between Pharma, Clinical Research Organizations (CROs) and...

CaroGen Corporation was founded by Drs. Bijan Almassian, Valerian Nakaar, Michael Robek, and John Rose to develop and commercialize novel immunotherapy approaches using the virus-like vesicle (VLV) platform. This patented platform was invented by...

Cell Culture Collective, Inc. is a leading provider of tissue culture reagents and consumables, headquartered in San Diego, California. Since its inception, the company has been committed to empowering research and further manufacturing endeavors in ...

Cyanvac LLC’s mission is to tackle the world’s most pressing infectious diseases with vaccines that can be easily delivered worldwide. We are a technology-driven company with a proprietary parainfluenza virus 5 (PIV5)-based vaccine platform. This...

Engimata Inc. was founded in 2019 to reduce vaccine wastage by developing thermostable adjuvants and vaccines that can be distributed at room temperature. Engimata’s mission is to create a more sustainable world by reducing vaccine wastage, and to...

EV Therapeutics is a pre-clinical staged neoantigen-based therapeutic cancer vaccine start-up focused on unlocking the full potential of the immune system to recognize and attack cancer by inducing an anti-tumor immune response in resistant...

Eyam's mission is to design and develop third generation vaccine technologies that create universal coverage and protection through our proprietary Gemini self-amplifying RNA and DNA platform. Leveraging the Jennerator Bioinformatics...

At the forefront of the DNA synthetic biology industry, GeneMeta Biotech LLC is revolutionizing biotech with significant advances in large-scale gene synthesis. With a specialization in gene synthesis, DNA storage, bio-manufacturing, and the...

Mural Health is a technology company that is dedicated to making it easier to be a participant in clinical trials. Mural Health’s technology platform, Mural Link, is a patient-first technology that is primarily designed for the benefit of the study...

NouBio is a VC-backed biotech company focused on the development of sustainable and animal-free products for biotechnology. NouBio has formulated a replacement for FBS in cell culture with significantly reduced cost and sustainability over FBS. In...

Omios Biologics is a privately held biotechnology company developing next generation Oncolytic Viral Immunotherapies with foundational intellectual property from New York University (NYU) and Arizona State University (ASU). Omios’ founding team...

Orlance, Inc., headquartered in Seattle, WA, is developing its MACH-1® platform to deliver nucleic acid vaccines and related therapies without cold chain restrictions.  Leveraging $13M in NIH SBIR funding, Orlance has developed the MACH-1 platform...

Paramita Therapeutics, Inc. (Paramita), founded by Drs. Sang Van and Jack Bui, began operations in 2018.  Paramita is an early-stage biotech startup focused on the development of novel targeted immunotherapies using our proprietary water-soluble...

Piezo Therapeutics aims to transform the delivery of nucleic acid medicines to enable improved safety, affordability, and scalability. Piezo is developing a uniquely engineered platform that uses electric pulses and microneedles to deliver a broad...

Q-Vant Biosciences, a privately-held multinational company, stands at the vanguard of innovation in the global human and animal vaccine markets. The company has revolutionized the industry by solving the persistent supply chain problem of QS-21 and...

Robust Diagnostics provides custom peptide microarray services to measure up to 150 epitope antibodies from a single sample. We work with our customers to develop highly sensitive and reproducible multiplex immunoassays that accelerate and empower...

Temperature excursions in your cold chain can be costly, and even dangerous. At sensified.io, our mission is to provide next generation monitoring solutions, using the latest wireless, mobile, and cloud technologies, to help you show your customers...

Tilda Research is a tech-forward site network & technology company committed to changing the way we do clinical research. We have developed a modern suite of tools as part our proprietary platform, leveraging the power of AI to consolidate & ...

Uvax Bio is a preclinical stage, privately funded biotechnology company focused on developing vaccines to address unmet clinical needs in the prevention of infectious diseases. Founded in 2018, Uvax Bio holds the exclusive worldwide rights to the...

Vaccinas.net is a unique vaccination platform that combines technology with service provision and provides a differentiated experience for clients, companies, and their employees. We have developed technological tools and innovative methodologies...

Our mission is to improve population health through digital health innovation. We aim to improve vaccination access, adherence and advance data driven research into vaccine-preventable diseases. The archaic reliance on paper-based vaccination logs...

Veergen, Inc. is a new biomedical technology start-up with the mission of developing vaccines that will be widely deployed to prevent outbreaks of emerging and prevalent viral diseases that affect global populations. We have developed a vaccine...

ViQi is modernizing image processing technology and expediting science discovery through the creation of AI-based assay development systems. Our technology not only generates better results and reduces employee oversight during testing, but our...

Vytokine Invigorating ImmunityVytokine develops innovative medicines to treat cancer and infectious diseases.Vytokine has developed a platform for displaying functional cytokines, Fv, or scF on chimeric human ferritin nanoparticles, which can be...